<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Trop Med Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">3447</journal-id><journal-id journal-id-type="pmc-domain">tropicalmed</journal-id><journal-id journal-id-type="publisher-id">tropicalmed</journal-id><journal-title-group><journal-title>Tropical Medicine and Infectious Disease</journal-title></journal-title-group><issn pub-type="epub">2414-6366</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474266</article-id><article-id pub-id-type="pmcid-ver">PMC12474266.1</article-id><article-id pub-id-type="pmcaid">12474266</article-id><article-id pub-id-type="pmcaiid">12474266</article-id><article-id pub-id-type="pmid">41003582</article-id><article-id pub-id-type="doi">10.3390/tropicalmed10090272</article-id><article-id pub-id-type="publisher-id">tropicalmed-10-00272</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development of a Microfluidic Point-of-Care Platform for HPV Detection Based on Helicase-Dependent Amplification</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6588-5856</contrib-id><name name-style="western"><surname>Gonz&#225;lez-Gonz&#225;lez</surname><given-names initials="E">Everardo</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-tropicalmed-10-00272" ref-type="aff">1</xref><xref rid="fn1-tropicalmed-10-00272" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Flores-Contreras</surname><given-names initials="EA">Elda A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af2-tropicalmed-10-00272" ref-type="aff">2</xref><xref rid="fn1-tropicalmed-10-00272" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1733-7366</contrib-id><name name-style="western"><surname>Trujillo-Rodr&#237;guez</surname><given-names initials="GDJ">Gerardo de Jes&#250;s</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-tropicalmed-10-00272" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6095-8817</contrib-id><name name-style="western"><surname>Jim&#233;nez-Mart&#237;nez</surname><given-names initials="ML">Mariana Lizbeth</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><xref rid="af3-tropicalmed-10-00272" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rodr&#237;guez-S&#225;nchez</surname><given-names initials="IP">Iram P.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="af3-tropicalmed-10-00272" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ancer-Arellano</surname><given-names initials="A">Adriana</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="af2-tropicalmed-10-00272" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alvarez-Cuevas</surname><given-names initials="S">Salomon</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-tropicalmed-10-00272" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1478-9068</contrib-id><name name-style="western"><surname>Martinez-Fierro</surname><given-names initials="ML">Margarita L.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af1-tropicalmed-10-00272" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marino-Mart&#237;nez</surname><given-names initials="IA">Iv&#225;n A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af2-tropicalmed-10-00272" ref-type="aff">2</xref><xref rid="c1-tropicalmed-10-00272" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6307-1696</contrib-id><name name-style="western"><surname>Garza-Veloz</surname><given-names initials="I">Idalia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-tropicalmed-10-00272" ref-type="aff">1</xref><xref rid="c1-tropicalmed-10-00272" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Batista</surname><given-names initials="MVDA">Marcus Vinicius de Arag&#227;o</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Chagas</surname><given-names initials="BS">B&#225;rbara Simas</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tropicalmed-10-00272"><label>1</label>Molecular Medicine Laboratory, Unidad Acad&#233;mica de Medicina Humana y Ciencias de la Salud, Universidad Aut&#243;noma de Zacatecas, Zacatecas 98160, Mexico; <email>dnarnaprot@gmail.com</email> (E.G.-G.); <email>entogerry36@gmail.com</email> (G.d.J.T.-R.); <email>margaritamf@uaz.edu.mx</email> (M.L.M.-F.)</aff><aff id="af2-tropicalmed-10-00272"><label>2</label>Departamento de Patolog&#237;a, Facultad de Medicina, Universidad Aut&#243;noma de Nuevo Le&#243;n, Francisco I. Madero y Dr. E. Aguirre Peque&#241;o s/n, Mitras Centro, Monterrey 64460, Mexico; <email>elda.florescn@uanl.edu.mx</email> (E.A.F.-C.); <email>adar7035@gmail.com</email> (A.A.-A.); <email>salomon.alvarezcv@uanl.edu.mx</email> (S.A.-C.)</aff><aff id="af3-tropicalmed-10-00272"><label>3</label>Laboratorio de Fisiolog&#237;a Molecular y Estructural, Facultad de Ciencias Biol&#243;gicas, Universidad Aut&#243;noma de Nuevo Le&#243;n, San Nicol&#225;s de los Garza 66455, Mexico; <email>mariana.jimenez80@gmail.com</email> (M.L.J.-M.); <email>iram.rodriguezsa@uanl.edu.mx</email> (I.P.R.-S.)</aff><author-notes><corresp id="c1-tropicalmed-10-00272"><label>*</label>Correspondence: <email>ivan.marinomr@uanl.edu.mx</email> (I.A.M.-M.); <email>idaliagv@uaz.edu.mx</email> (I.G.-V.)</corresp><fn id="fn1-tropicalmed-10-00272"><label>&#8224;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>10</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497678</issue-id><elocation-id>272</elocation-id><history><date date-type="received"><day>09</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>9</month><year>2025</year></date><date date-type="accepted"><day>17</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 12:25:14.207"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="tropicalmed-10-00272.pdf"/><abstract><p>Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide and a leading cause of cervical cancer, accounting for over 300,000 deaths annually, primarily due to high-risk genotypes HPV-16 and HPV-18. Conventional molecular diagnostic methods, such as polymerase chain reaction (PCR), require expensive instrumentation and well-equipped laboratories, which limits their applicability in low-resource or decentralized settings. To address this challenge, the aim of this study was to develop a prototype point-of-care (POC) diagnostic platform based on helicase-dependent amplification (HDA) integrated into a microfluidic device for the specific detection of HPV-16 and HPV-18. The proposed POC platform comprises a disposable poly (methyl methacrylate) (PMMA) microfluidic device, a portable warming mat for isothermal amplification at 65 &#176;C, and a compact electrophoresis chamber for fluorescence-based visualization using SYBR Safe dye, with an approximate total cost of $320 USD. Platform validation was performed on 33 samples, demonstrating amplification of target sequences in less than 60 min with only 20 &#181;L of reaction volume, a limit of detection (LOD) of 15 copies (cp) per reaction, a sensitivity of 95.52%, and a specificity of 100%. This portable and scalable platform constitutes a cost-effective and reliable tool for the detection of HPV, supporting global health initiatives, including those driven by the World Health Organization (WHO), aimed at eliminating cervical cancer as a public health threat, as it can be implemented in decentralized or resource-limited settings.</p></abstract><kwd-group><kwd>HPV</kwd><kwd>diagnostics</kwd><kwd>HDA</kwd><kwd>microfluidics</kwd><kwd>POC</kwd><kwd>PCR</kwd><kwd>isothermal amplification</kwd></kwd-group><funding-group><funding-statement>This research did not receive external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-tropicalmed-10-00272"><title>1. Introduction</title><p>The human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus with a circular genome, classified within the <italic toggle="yes">Papillomaviridae</italic> family [<xref rid="B1-tropicalmed-10-00272" ref-type="bibr">1</xref>]. It is primarily spread through skin-to-skin contact and represents the most common sexually transmitted infection globally. HPV predominantly targets the reproductive tract by infecting the epithelial cells of the skin and mucous membranes [<xref rid="B2-tropicalmed-10-00272" ref-type="bibr">2</xref>,<xref rid="B3-tropicalmed-10-00272" ref-type="bibr">3</xref>].</p><p>HPV is one of the leading causes of cervical cancer in women, accounting for approximately 660,000 new cases and 350,000 deaths worldwide in 2022 [<xref rid="B4-tropicalmed-10-00272" ref-type="bibr">4</xref>].</p><p>Given its high prevalence and significant impact on global health, the World Health Organization (WHO) has launched the &#8220;90-70-90&#8221; Global Strategy to Eliminate Cervical Cancer, aiming to achieve elimination by 2030 [<xref rid="B4-tropicalmed-10-00272" ref-type="bibr">4</xref>]. The strategy includes three key targets:<list list-type="order"><list-item><p>Vaccinate 90% of girls under 15 years of age.</p></list-item><list-item><p>Ensure that 70% of women receive high-throughput screening in two rounds: the first before age 35 and the second before age 45.</p></list-item><list-item><p>Provide appropriate treatment for 90% of women diagnosed with HPV infection, precancerous lesions, or invasive cervical cancer.</p></list-item></list></p><p>To support the second and third pillars of this strategy, it is essential to implement accessible, accurate, efficient diagnostic and monitoring tools that provide rapid results. Current molecular diagnostic tests for HPV primarily target high-risk genotypes associated with the development of cervical cancer, including types 16 and 18. These genotypes are responsible for over 70% of cervical cancer cases. Detection is commonly carried out using end-point or quantitative PCR (qPCR) techniques [<xref rid="B4-tropicalmed-10-00272" ref-type="bibr">4</xref>,<xref rid="B5-tropicalmed-10-00272" ref-type="bibr">5</xref>,<xref rid="B6-tropicalmed-10-00272" ref-type="bibr">6</xref>]. Although these tests offer high sensitivity and specificity, they require a specialized infrastructure, highly trained personnel, and expensive equipment, such as thermal cyclers [<xref rid="B7-tropicalmed-10-00272" ref-type="bibr">7</xref>]. Consequently, the establishment of a molecular diagnostic laboratory can exceed US $100,000, with total cost varying depending on infrastructure, equipment, and operational scales, thus limiting their viability in low-resource settings [<xref rid="B8-tropicalmed-10-00272" ref-type="bibr">8</xref>].</p><p>To overcome these limitations, point-of-care (POC) diagnostic tests have emerged as viable alternatives, such as isothermal amplification assays. These tests operate at a constant temperature and enable the amplification of specific DNA sequences, delivering results in less than 60 min [<xref rid="B9-tropicalmed-10-00272" ref-type="bibr">9</xref>,<xref rid="B10-tropicalmed-10-00272" ref-type="bibr">10</xref>,<xref rid="B11-tropicalmed-10-00272" ref-type="bibr">11</xref>,<xref rid="B12-tropicalmed-10-00272" ref-type="bibr">12</xref>]. Their simplicity allows testing to be performed near or at the location of the patient, significantly reducing reliance on complex laboratory infrastructure [<xref rid="B13-tropicalmed-10-00272" ref-type="bibr">13</xref>]. Moreover, they offer the added advantage of enabling accessible, preventive, and timely diagnoses [<xref rid="B9-tropicalmed-10-00272" ref-type="bibr">9</xref>,<xref rid="B10-tropicalmed-10-00272" ref-type="bibr">10</xref>,<xref rid="B11-tropicalmed-10-00272" ref-type="bibr">11</xref>].</p><p>Helicase-dependent amplification (HDA) is one of the notable isothermal amplification methods, which utilizes a DNA helicase (UvrD from <italic toggle="yes">Escherichia coli</italic>), single-stranded DNA-binding proteins (SSB), and two specific primers to amplify the target sequence [<xref rid="B14-tropicalmed-10-00272" ref-type="bibr">14</xref>]. Helicase separates the duplex DNA strands, and SSB proteins prevent strand reannealing, allowing the primers to bind to the template strands. The polymerase synthesizes the complementary strand from the primers [<xref rid="B14-tropicalmed-10-00272" ref-type="bibr">14</xref>,<xref rid="B15-tropicalmed-10-00272" ref-type="bibr">15</xref>]. In contrast to loop-mediated isothermal amplification (LAMP), the HDA test employs a simpler primer design similar to conventional PCR, requiring no more than two primers and no complex secondary structures. Notably, LAMP exhibits a higher false-positive rate (up to ~28%), mainly due to nonspecific amplification of non-target DNA, such as primer dimers and contaminating DNA, while HDA exhibits a considerably lower rate (&lt;10%) [<xref rid="B14-tropicalmed-10-00272" ref-type="bibr">14</xref>,<xref rid="B16-tropicalmed-10-00272" ref-type="bibr">16</xref>,<xref rid="B17-tropicalmed-10-00272" ref-type="bibr">17</xref>,<xref rid="B18-tropicalmed-10-00272" ref-type="bibr">18</xref>,<xref rid="B19-tropicalmed-10-00272" ref-type="bibr">19</xref>]. This simplicity makes HDA a more straightforward alternative among isothermal amplification techniques. Isothermal methods are usually combined with microfluidic techniques and biosensors and which allow for a lower detection limit and reaction volume [<xref rid="B9-tropicalmed-10-00272" ref-type="bibr">9</xref>,<xref rid="B20-tropicalmed-10-00272" ref-type="bibr">20</xref>,<xref rid="B21-tropicalmed-10-00272" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00272" ref-type="bibr">22</xref>]. To date, this combination has primarily involved LAMP with microfluidic chips for the detection of high-risk HPV genotypes [<xref rid="B23-tropicalmed-10-00272" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00272" ref-type="bibr">24</xref>,<xref rid="B25-tropicalmed-10-00272" ref-type="bibr">25</xref>]. Although HDA has been successfully applied for detecting bacteria such as <italic toggle="yes">E. coli</italic>, methicillin-resistant <italic toggle="yes">Staphylococcus</italic> strains, <italic toggle="yes">Listeria monocytogenes</italic>, hepatitis B virus, coronavirus, and monkeypox virus, no microfluidic HDA platform has yet been developed for HPV detection [<xref rid="B26-tropicalmed-10-00272" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00272" ref-type="bibr">27</xref>,<xref rid="B28-tropicalmed-10-00272" ref-type="bibr">28</xref>,<xref rid="B29-tropicalmed-10-00272" ref-type="bibr">29</xref>,<xref rid="B30-tropicalmed-10-00272" ref-type="bibr">30</xref>,<xref rid="B31-tropicalmed-10-00272" ref-type="bibr">31</xref>].</p><p>In this context, the aim of this study was to develop a POC diagnostic platform based on HDA, integrated into a microfluidic device, for the specific detection of HPV genotypes 16 and 18.</p></sec><sec id="sec2-tropicalmed-10-00272"><title>2. Materials and Methods</title><sec id="sec2dot1-tropicalmed-10-00272"><title>2.1. Ethical Considerations</title><p>Participants selected for the study were all over 18 years of age. Individuals with mental disabilities and allergies to the medications used in the treatment were excluded. Written informed consent was obtained from all patients for the collection, storage, and subsequent analysis of their samples. Sample analysis was performed anonymously to ensure participant confidentiality. The study protocol was reviewed and approved by the Ethics Committee of Hospital Universitario &#8220;Dr. Jos&#233; Eleuterio Gonz&#225;lez&#8221;, Universidad Aut&#243;noma de Nuevo Le&#243;n (Monterrey, Nuevo Le&#243;n, Mexico) under protocol number PA15-001.</p></sec><sec id="sec2dot2-tropicalmed-10-00272"><title>2.2. Sample Collection and Processing</title><p>Thirty cervical histological tissue samples from Mexican patients were collected between 2024 and 2025 at the Hospital Universitario &#8220;Dr. Jos&#233; Eleuterio Gonz&#225;lez&#8221;. Genomic DNA was extracted from 25 mg of tissue using the NucleoSpin<sup>&#174;</sup> Tissue Kit (Macherey-Nagel, D&#252;ren, Germany), following the manufacturer&#8217;s protocol. DNA concentration and purity were assessed using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Purity was evaluated based on the absorbance ratios at 260/280 and 260/230 nm. DNA concentrations in the samples ranged from 10 to 100 ng/&#181;L. Extracted DNA samples were stored at &#8722;20 &#176;C until further analysis.</p></sec><sec id="sec2dot3-tropicalmed-10-00272"><title>2.3. Genotyping of DNA Samples</title><p>The collected DNA samples were analyzed using the QuantStudio&#8482; 3 real-time PCR system (Thermo Fisher Scientific, Waltham, MA, USA), employing the GeneProof HPV PCR kit (GeneProof, Brno-jih, Czech Republic). This kit allows the detection of high-risk HPV genotypes 16, 18 and 45 through genotype-specific fluorescent probes (<xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>).</p><p>In addition, three controls were included: one sample positive for low-risk HPV genotype 6 (sample 31, <xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>) and another sample positive for <italic toggle="yes">Chlamydia trachomatis</italic> but negative for HPV (sample 32, <xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>). Both were kindly provided by the Department of Pathology at the Universidad Aut&#243;noma de Nuevo Le&#243;n. The third control was a plasmid containing the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) sequence, synthesized by GenScript (Piscataway, NJ, USA) (sample 33, <xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>); the plasmid map and integrated viral sequence are provided in the <xref rid="app1-tropicalmed-10-00272" ref-type="app">Supplementary Materials (Figure S1)</xref>.</p></sec><sec id="sec2dot4-tropicalmed-10-00272"><title>2.4. Standardization of the HDA Reaction Conditions</title><p>The HDA was standardized to determine the optimal temperature and incubation time. A DNA pool (mixture of 20 samples) positive for HPV genotypes 16 and 18, extracted from cervical tissue samples, was used as a positive control. This DNA was kindly provided by the Department of Pathology at the Universidad Aut&#243;noma de Nuevo Le&#243;n. Regarding the negative control, nuclease-free water was included instead of a DNA template to validate the absence of contamination or the obtaining of non-specific amplification products.</p><p>The IsoAmp<sup>&#174;</sup> II Universal tHDA kit (New England Biolabs, Ipswich, MA, USA) was used to perform the HDA test. Each reaction was prepared in a final volume of 50 &#181;L in microtubes, containing 5 &#181;L of 10X Annealing Buffer II, 2 &#181;L of MgSO<sub>4</sub> (100 mM), 4 &#181;L of NaCl (500 mM), 1.5 &#181;L each of forward and reverse primers (1 &#181;M) (<xref rid="tropicalmed-10-00272-t002" ref-type="table">Table 2</xref>), 3.5 &#181;L of IsoAmp<sup>&#174;</sup> dNTP Solution, 3.5 &#181;L of IsoAmp<sup>&#174;</sup> Enzyme Mix, 5 &#181;L of DNA template (10 ng), and nuclease-free water to adjust the final volume.</p><p>Reactions were incubated at temperatures ranging from 55 &#176;C to 65 &#176;C for 30 to 120 min using a SimpliAmp thermal cycler (Thermo Fisher Scientific, Waltham, MA, USA). Amplification products were analyzed by electrophoresis on a 4% agarose gel stained with SYBR Safe (1&#215;) (Thermo Fisher Scientific, Waltham, MA, USA), employing a DNA ladder from Promega (Sunnyvale, CA, USA) covering a size range of 100 to 1500 base pairs (bp). Additionally, the detection limit (LOD) was determined using a synthetic control corresponding to a purified plasmid containing sequences from HPV genotypes 16 and 18, provided by the Department of Pathology at the Universidad Aut&#243;noma de Nuevo Le&#243;n. The plasmid concentration was measured using a NanoDrop 1000 spectrophotometer, and the copy number per microliter was calculated using the following formula: viral copy number (cp/&#956;L) = (6.02 &#215; 10<sup>&#8722;2</sup>) &#215; (measured value &#215; 10<sup>&#8722;9</sup>)/(DNA length &#215; 660). The plasmid was subsequently diluted to obtain a copy number range of 30 to 1, in order to determine the LOD of the HDA assay under previously standardized conditions. The resulting products were evaluated under the same electrophoretic conditions. All reactions were carried out in triplicate.</p></sec><sec id="sec2dot5-tropicalmed-10-00272"><title>2.5. Design and Fabrication of the Microfluidic Device</title><p>The design was created using AutoCAD 2024 (Autodesk Inc., San Francisco, CA, USA) and manufactured using poly (methyl methacrylate) (PMMA); the components were laser-cut, assembled, and sealed with chloroform. The device measures 2 cm &#215; 2 cm, as illustrated in <xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>A, and has two chambers with a total capacity of 20 &#181;L, allowing for even heat distribution and leak-proofing to carry out the HDA reaction. <xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S2</xref> shows the AutoCAD model of the microfluidic device.</p></sec><sec id="sec2dot6-tropicalmed-10-00272"><title>2.6. Performance and Analysis of HDA Assays on the Microfluidic Platform</title><p>The HDA reaction integrated into the microfluidic platform was performed in a total volume of 20 &#181;L, consisting of the following components: 2 &#181;L of 10X Hybridization Buffer II, 0.8 &#181;L of MgSO<sub>4</sub> (100 mM), 1.6 &#181;L of NaCl (500 mM), 0.6 &#181;L of forward and reverse primers (1 &#181;M) (<xref rid="tropicalmed-10-00272-t002" ref-type="table">Table 2</xref>), 1.4 &#181;L of IsoAmp<sup>&#174;</sup> dNTP solution, 1.4 &#181;L of IsoAmp<sup>&#174;</sup> enzyme mix, 2 &#181;L of template DNA (1&#8211;10 ng), and nuclease-free water to complete the final volume. The reaction was performed under pre-standardized conditions, and the assay functionality was validated using 33 pre-genotyped samples. After sample loading, the microfluidic chips were incubated on a portable warming mat (DAMET, Shenzhen China) (<xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>B) at 65 &#176;C for 60 min. Following incubation, 1 &#181;L of SYBR Safe (2000X stock solution) was added to each chip (33 in total), resulting in a final concentration of 20X. The chips were placed in a portable electrophoresis chamber (Amplyus LLC, Boston, MA, USA) equipped with a blue light source (<xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>C), enabling fluorescence visualization to be correlated with the presence of HPV genotypes 16 or 18 in the samples. Furthermore, chip images were processed using ImageJ 1.53t software (National Institutes of Health, Bethesda, MD, USA), analyzing the signal intensity with the blue channel. (<xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S3</xref>). To confirm the results, electrophoresis was performed using 4% agarose gels using the portable electrophoresis chamber. <xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>D shows the general scheme followed to perform the HDA test integrated into the microfluidic platform, and <xref rid="tropicalmed-10-00272-t003" ref-type="table">Table 3</xref> shows the costs of the components.</p></sec><sec id="sec2dot7-tropicalmed-10-00272"><title>2.7. POC Platform</title><p>The following elements were employed to carry out HPV amplification via HDA: (A) a microfluidic device, (B) a portable warming mat, and (C) a portable electrophoresis chamber. <xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref> shows the components of the POC platform. The platform is composed of accessible and portable components, allowing the system to have a low cost (approximately $320 USD). Detection is achieved through the emission of green fluorescence in the presence of target DNA. This signal results from the binding of SYBR Safe dye to the double-stranded DNA amplified by HDA; once bound, the dye fluoresces upon excitation with blue light. The platform supports low-volume reactions (20 &#181;L), enabling rapid detection (in less than 60 min), assessment of treatment efficacy, and monitoring of disease progression associated with HPV-related cervical cancer.</p></sec><sec id="sec2dot8-tropicalmed-10-00272"><title>2.8. Statistical Analysis</title><p>Statistical analysis was performed using Minitab<sup>&#174;</sup> 2025 software (Minitab Inc., Centre County, PA, USA) using attribute agreement analysis to assess the reliability of the HDA test.</p></sec></sec><sec sec-type="results" id="sec3-tropicalmed-10-00272"><title>3. Results</title><sec id="sec3dot1-tropicalmed-10-00272"><title>3.1. Standardization of Reaction Conditions</title><p>To optimize the HDA assay for the detection of HPV genotypes 16 and 18, a temperature gradient from 55 &#176;C to 65 &#176;C was evaluated. A pooled DNA sample positive for HPV genotypes 16 and 18, obtained from cervical tissue, was used as the positive control. For the negative control, the amplification reaction was performed in the absence of template DNA. Reactions were prepared in 50 &#181;L volumes using Eppendorf tubes and carried out according to the IsoAmp<sup>&#174;</sup> II Universal tHDA Kit protocol. Each reaction was incubated for 90 min. The results indicated that the optimal amplification temperature was 65 &#176;C (<xref rid="tropicalmed-10-00272-f002" ref-type="fig">Figure 2</xref>A,B). At this temperature, an amplification band of approximately 83 bp was observed for genotype 16 (<xref rid="tropicalmed-10-00272-f002" ref-type="fig">Figure 2</xref>A) and a band of approximately 108 bp for genotype 18 (<xref rid="tropicalmed-10-00272-f002" ref-type="fig">Figure 2</xref>B).</p><p>To establish the optimal reaction time, HDA reactions with primers targeting HPV18 were incubated for 30&#8211;120 min. Amplification products were detectable within 30 min (<xref rid="tropicalmed-10-00272-f002" ref-type="fig">Figure 2</xref>C). The LOD of the assay was also evaluated using a synthetic control containing HPV16 and HPV18 sequences, under standardized conditions. The LOD was 15 cp per reaction for both genotypes (<xref rid="tropicalmed-10-00272-f002" ref-type="fig">Figure 2</xref>D).</p></sec><sec id="sec3dot2-tropicalmed-10-00272"><title>3.2. Detection of HPV Genotypes 16 and 18 Using the POC Platform</title><p>Following the optimization of reaction conditions in microtubes, HDA was implemented on the 2 cm &#215; 2 cm microfluidic device (<xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>A) using 20 &#181;L reaction volumes. A total of thirty-three samples were processed on the chip using specific primers for HPV 16 and 18, followed by incubation at 65 &#176;C (verified with an infrared thermometer) for 60 min on a portable warming mat (<xref rid="tropicalmed-10-00272-f003" ref-type="fig">Figure 3</xref>A). A run time of 60 min was chosen due to the high variability in patient sample quality. This was done to ensure sufficient time for HDA. Post-incubation, amplification products were analyzed by electrophoresis on a 4% agarose gel and visualized under blue light using the electrophoresis chamber (<xref rid="tropicalmed-10-00272-f001" ref-type="fig">Figure 1</xref>C).</p><p>In parallel, the samples were stained with SYBR Safe to enable direct, on-chip visual detection of HPV genotypes 16 and 18. Under blue light, positive samples exhibited a green fluorescent signal, while negative samples displayed an orange signal.</p><p>The results obtained by gel electrophoresis (<xref rid="tropicalmed-10-00272-f003" ref-type="fig">Figure 3</xref>B,C) and SYBR Safe (<xref rid="tropicalmed-10-00272-f003" ref-type="fig">Figure 3</xref>D and <xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S4</xref>) were consistent with the real-time PCR analysis (<xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>), except for sample 20, which was negative in the HDA assay and positive by real-time PCR (<xref rid="tropicalmed-10-00272-t001" ref-type="table">Table 1</xref>) and (<xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S4</xref>). Thus, the assay showed a sensitivity of 95.52% and a specificity of 100%, with a kappa of 0.936 (95% CI: 84.24&#8211;99.92, <italic toggle="yes">p</italic> &lt; 0.05) (<xref rid="tropicalmed-10-00272-t004" ref-type="table">Table 4</xref>). Furthermore, it is important to highlight that no cross-reactions were observed between samples positive for HPV 6 (<xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S4</xref>), <italic toggle="yes">Chlamydia trachomatis</italic> (<xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S4</xref>) and PRRSV (<xref rid="app1-tropicalmed-10-00272" ref-type="app">Figure S4</xref>) when primers for the detection of HPV 16 and 18 were used. However, larger-scale studies are needed to validate these performance metrics and determine their consistency in larger clinical settings.</p></sec></sec><sec sec-type="discussion" id="sec4-tropicalmed-10-00272"><title>4. Discussion</title><p>Here, we report a prototype microfluidic platform integrating helicase-dependent amplification (HDA) for the simple, cost-effective detection of high-risk HPV genotypes 16 and 18 in a point-of-care (POC) setting.</p><p>Test conditions were standardized using a pooled sample containing both genotypes, enabling biological heterogeneity and the inclusion of a broader range of variables. This strategy reduces operational costs and minimizes the number of individual tests required, while ensuring reliable platform performance [<xref rid="B32-tropicalmed-10-00272" ref-type="bibr">32</xref>,<xref rid="B33-tropicalmed-10-00272" ref-type="bibr">33</xref>].</p><p>Among the findings of this POC platform is the obtaining of results around 60 min, with a LOD of 15 cp per reaction. Moreover, the platform demonstrated a sensitivity of 95.52% and a specificity of 100%, with only one false negative detected, likely due to target DNA degradation or the presence of inhibitors in the sample that interfered with isothermal amplification [<xref rid="B34-tropicalmed-10-00272" ref-type="bibr">34</xref>]. In addition, no cross-reactivity was observed with other HPV genotypes (e.g., type 6), sexually transmitted infections such as <italic toggle="yes">Chlamydia trachomatis</italic>, or viruses from other species such as PRRSV. These features are comparable to those reported for other isothermal amplification methods used for HPV detection, which typically require 60 to 120 min and detect target sequences using DNA inputs below 100 cp per reaction, with sensitivities and specificities ranging from 84% to 100% [<xref rid="B9-tropicalmed-10-00272" ref-type="bibr">9</xref>,<xref rid="B24-tropicalmed-10-00272" ref-type="bibr">24</xref>,<xref rid="B35-tropicalmed-10-00272" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00272" ref-type="bibr">36</xref>].</p><p>Furthermore, this microfluidic platform allows the use of a significantly reduced reaction volume of 20 &#181;L, unlike standard HDA assays that require reaction volumes of around 50 &#181;L, and other isothermal POC systems that often exceed reaction volumes of 30 &#181;L, thereby reducing the overall cost of reactions [<xref rid="B15-tropicalmed-10-00272" ref-type="bibr">15</xref>,<xref rid="B37-tropicalmed-10-00272" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00272" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00272" ref-type="bibr">39</xref>]. This is possible due to the miniaturized design of the chambers, which are noticeably smaller than conventional PCR tubes (capacity of 200 &#181;L). The reduced scale increases the efficiency of the amplification process by facilitating heat transfer, and this configuration also helps minimize reagent consumption. Another key advantage is that using a microfluidic chip instead of conventional microtubes offers significant biosafety benefits. The design reduces the risk of sample leakage, aerosol formation, and cross-contamination during amplification, common problems associated with manual handling and opening of microtubes [<xref rid="B40-tropicalmed-10-00272" ref-type="bibr">40</xref>]. It also provides greater protection for users and minimizes environmental exposure. Therefore, the platform&#8217;s design is ideal for deployment in low-resource settings, especially where the presence of multiple pathogens increases the risk of cross-contamination.</p><p>The isothermal nature of the HDA enabled incubation using a portable warming mat, contributing to a user-friendly and cost-efficient setup. This simple POC platform allows for the incubation of more than 60 samples per hour, resulting in a processing capacity of several hundred samples per day. Notably, the performance of this platform is comparable to that of HPV detection systems currently recommended by the Pan American Health Organization (PAHO) WHO, which offer processing capacities ranging from 45 to 471 samples per day. Nevertheless, comparative studies using clinical samples are necessary to accurately evaluate its performance and operational feasibility [<xref rid="B41-tropicalmed-10-00272" ref-type="bibr">41</xref>]. The flexibility of this technology allows it to be adapted to detect a wide range of pathogens, enabling large-scale diagnostics. This versatility is advantageous during public health crises, such as pandemics, where rapid and decentralized testing is essential [<xref rid="B42-tropicalmed-10-00272" ref-type="bibr">42</xref>,<xref rid="B43-tropicalmed-10-00272" ref-type="bibr">43</xref>].</p><p>On the other hand, the use of SYBR Safe as a fluorescent marker enables rapid and straightforward interpretation of results. While the application of SYBR Safe in HDA assays has not been previously reported, a study by Yamket et al. (2023) demonstrated the use of SYBR Green following HDA to detect bacterial DNA in platelet samples [<xref rid="B38-tropicalmed-10-00272" ref-type="bibr">38</xref>]. In that study, green fluorescence was observed under UV light in the presence of amplified products, supporting the feasibility of using intercalating dyes for post-amplification detection [<xref rid="B38-tropicalmed-10-00272" ref-type="bibr">38</xref>].</p><p>In this context, the platform stands out for its operational simplicity, without the need for multiple steps that complicate its use. Although there are innovative isothermal diagnostic systems, their implementation often involves extra procedural steps, for example, the system developed by Kundrod et al. (2023), which detects HPV genotypes 16 and 18 by isothermal recombinase polymerase amplification (RPA) followed by detection using lateral flow strips [<xref rid="B44-tropicalmed-10-00272" ref-type="bibr">44</xref>]. Similarly, the platform developed by Zamani et al. (2021) involves a more elaborate workflow, combining LAMP with CRISPR-Cas technology and a biosensor capable of detecting electrochemical signals produced by activated Cas enzymes in the presence of the amplified target DNA [<xref rid="B45-tropicalmed-10-00272" ref-type="bibr">45</xref>].</p><p>Another significant advantage of the developed platform is its low implementation cost, estimated at US $320.10 (<xref rid="tropicalmed-10-00272-t002" ref-type="table">Table 2</xref>), which is lower than that of currently commercially available POC tests such as careHPV (Qiagen, Hilden, Germany), with instrumentation costs of around US $20,000, and GeneXpert (Cepheid, Sunnyvale, CA, USA), whose implementation costs range from US $11,530 to US $71,500 [<xref rid="B8-tropicalmed-10-00272" ref-type="bibr">8</xref>]. In addition, it is notably more affordable than conventional HPV diagnostic systems, which typically require equipment such as thermal cyclers and specialized laboratory infrastructure, with acquisition costs ranging from US $11,500 to US $150,000 [<xref rid="B8-tropicalmed-10-00272" ref-type="bibr">8</xref>,<xref rid="B46-tropicalmed-10-00272" ref-type="bibr">46</xref>,<xref rid="B47-tropicalmed-10-00272" ref-type="bibr">47</xref>]. Therefore, this platform is suitable for future implementation in low-cost mobile laboratories (at a cost of less than $2500 USD), for example, using greenhouses equipped with basic instrumentation and powered by a portable battery-based supply (<xref rid="tropicalmed-10-00272-f004" ref-type="fig">Figure 4</xref> illustrates the concept described above). This approach enables deployment in remote areas where access to molecular diagnostics is limited or unavailable. Such laboratory concepts can be of significant value in resource-limited regions and, in the context of pandemics or outbreaks, may play a critical role in controlling disease transmission and saving millions of lives.</p><p>Despite the multiple advantages demonstrated by this proof of concept, several areas of opportunity remain to be addressed. A key limitation is the need to increase the sample size for large-scale clinical validation of the platform, which is essential to establish its robustness and generalizability.</p><p>In addition, isothermal amplification on the developed platform currently requires a prior DNA extraction step. To address this, the future integration of a rapid and user-friendly DNA lysis and extraction step directly onto the chip is planned. Likewise, additional work is required to standardize and evaluate alternative fluorescent or colorimetric dyes to identify the most suitable option that allows for real-time, naked-eye interpretation of results without the need for an electrophoresis chamber, thereby improving usability in field settings. Another option is the integration of an automated DNA extraction and signal reading system, which would reduce user dependency and increase the overall reliability of the platform.</p></sec><sec sec-type="conclusions" id="sec5-tropicalmed-10-00272"><title>5. Conclusions</title><p>In this pilot study, we developed a POC platform based on isothermal HDA testing for the detection of HPV genotypes 16 and 18, achieving amplification of target DNA in 60 min, with a LOD of 15 cp per reaction. This work demonstrates that accessible, simple, and low-cost components can enable the development of practical and attractive diagnostic solutions. As a proof of concept, this platform represents a promising tool for future implementation in remote areas, where access to molecular diagnostics is often limited by high costs and infrastructure requirements. This platform costs approximately $320 USD, making it an ideal diagnostic test for the development of mobile laboratories using greenhouses and basic instrumentation. This approach will allow the establishment of functional molecular testing workspaces at a total cost of less than $2500 USD, with substantial test processing capacity, and can be applied to detect different pathogens.</p></sec></body><back><ack><title>Acknowledgments</title><p>We gratefully acknowledge the support provided by the Secretar&#237;a de Ciencia, Humanidades, Tecnolog&#237;a e Innovaci&#243;n (SECIHTI).</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-tropicalmed-10-00272"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/tropicalmed10090272/s1">https://www.mdpi.com/article/10.3390/tropicalmed10090272/s1</uri>; Figure S1: DNA vector map containing viral sequences of the PRRSV, used as a negative control for the HDA assay analysis; Figure S2: AutoCAD model used for the design and fabrication of the microfluidic system; Figure S3: Image analysis of the chip with HDA reactions was generated using ImageJ1.53t software, processing data specifically from the blue channel; Figure S4: Results of agarose gel electrophoresis from the HDA assay. (A&#8211;C) Results of samples 13 to 30. (D) Results of negative controls, including HPV-6, <italic toggle="yes">Chlamydia trachomatis</italic> (CT), and PRRSV.</p><supplementary-material id="tropicalmed-10-00272-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tropicalmed-10-00272-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>E.G.-G. and E.A.F.-C.: conceptualization, methodology, revision, and writing of the manuscript. I.G.-V. and I.A.M.-M.: manuscript writing, supervision and editing. G.d.J.T.-R., I.P.R.-S., S.A.-C., M.L.M.-F., A.A.-A. and M.L.J.-M.: manuscript writing and editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the &#8220;Dr. Jos&#233; Eleuterio Gonz&#225;lez&#8221; Hospital Universitario of the Universidad Aut&#243;noma de Nuevo Le&#243;n (PA15-001, 15 January 2024).</p></notes><notes><title>Informed Consent Statement</title><p>All participants were over 18 years of age. Written informed consent was obtained from all participants for the collection, storage, and subsequent analysis of samples.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-tropicalmed-10-00272" ref-type="app">Supplementary Material</xref>. Further inquiries can be directed to the corresponding authors.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">bp</td><td align="left" valign="middle" rowspan="1" colspan="1">Base Pairs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">cp</td><td align="left" valign="middle" rowspan="1" colspan="1">Copies</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CI</td><td align="left" valign="middle" rowspan="1" colspan="1">Confidence interval</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDA</td><td align="left" valign="middle" rowspan="1" colspan="1">Helicase-Dependent Amplification</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HPV</td><td align="left" valign="middle" rowspan="1" colspan="1">Human Papillomavirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LOD</td><td align="left" valign="middle" rowspan="1" colspan="1">Limit of detection</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PAHO</td><td align="left" valign="middle" rowspan="1" colspan="1">Pan American Health Organization</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">POC</td><td align="left" valign="middle" rowspan="1" colspan="1">Point-of-care</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PMMA</td><td align="left" valign="middle" rowspan="1" colspan="1">Poly(methyl methacrylate) PMMA</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RPA</td><td align="left" valign="middle" rowspan="1" colspan="1">Recombinase polymerase amplification</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SSB</td><td align="left" valign="middle" rowspan="1" colspan="1">Single-Stranded DNA Binding Proteins</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WHO</td><td align="left" valign="middle" rowspan="1" colspan="1">World Health Organization</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-tropicalmed-10-00272"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Doorslaer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>H.U.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>P.K.S.</given-names></name><name name-style="western"><surname>Desalle</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dillner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Forslund</surname><given-names>O.</given-names></name><name name-style="western"><surname>Haga</surname><given-names>T.</given-names></name><name name-style="western"><surname>McBride</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Villa</surname><given-names>L.L.</given-names></name><etal/></person-group><article-title>ICTV Virus Taxonomy Profile: Papillomaviridae</article-title><source>J. Gen. Virol.</source><year>2018</year><volume>99</volume><fpage>989</fpage><pub-id pub-id-type="doi">10.1099/jgv.0.001105</pub-id><pub-id pub-id-type="pmid">29927370</pub-id><pub-id pub-id-type="pmcid">PMC6171710</pub-id></element-citation></ref><ref id="B2-tropicalmed-10-00272"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinlan</surname><given-names>J.D.</given-names></name></person-group><article-title>Human Papillomavirus: Screening, Testing, and Prevention Human Papillomavirus</article-title><source>Am. Fam. Physician</source><year>2021</year><volume>104</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">34383440</pub-id></element-citation></ref><ref id="B3-tropicalmed-10-00272"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Sanjose</surname><given-names>S.</given-names></name><name name-style="western"><surname>Quint</surname><given-names>W.G.V.</given-names></name><name name-style="western"><surname>Alemany</surname><given-names>L.</given-names></name><name name-style="western"><surname>Geraets</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Klaustermeier</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Lloveras</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tous</surname><given-names>S.</given-names></name><name name-style="western"><surname>Felix</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H.R.</given-names></name><etal/></person-group><article-title>Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study</article-title><source>Lancet. Oncol.</source><year>2010</year><volume>11</volume><fpage>1048</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(10)70230-8</pub-id><pub-id pub-id-type="pmid">20952254</pub-id></element-citation></ref><ref id="B4-tropicalmed-10-00272"><label>4.</label><element-citation publication-type="webpage"><article-title>Human Papillomavirus and Cancer</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-22">(accessed on 22 July 2025)</date-in-citation></element-citation></ref><ref id="B5-tropicalmed-10-00272"><label>5.</label><element-citation publication-type="webpage"><article-title>Human Papillomavirus (HPV) Vaccine&#8212;PAHO/WHO|Pan American Health Organization</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.paho.org/en/human-papillomavirus-hpv-vaccine" ext-link-type="uri">https://www.paho.org/en/human-papillomavirus-hpv-vaccine</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-11-06">(accessed on 6 November 2023)</date-in-citation></element-citation></ref><ref id="B6-tropicalmed-10-00272"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kostiuk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Biron</surname><given-names>V.L.</given-names></name></person-group><article-title>Molecular Detection Methods in HPV-Related Cancers</article-title><source>Front. Oncol.</source><year>2022</year><volume>12</volume><elocation-id>864820</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.864820</pub-id><pub-id pub-id-type="pmid">35574396</pub-id><pub-id pub-id-type="pmcid">PMC9092940</pub-id></element-citation></ref><ref id="B7-tropicalmed-10-00272"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teymouri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mollazadeh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mortazavi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Naderi Ghale-noie</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Keyvani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Aghababaei</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hamblin</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Abbaszadeh-Goudarzi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pourghadamyari</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hashemian</surname><given-names>S.M.R.</given-names></name><etal/></person-group><article-title>Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19</article-title><source>Pathol. Res. Pract.</source><year>2021</year><volume>221</volume><fpage>153443</fpage><pub-id pub-id-type="doi">10.1016/j.prp.2021.153443</pub-id><pub-id pub-id-type="pmid">33930607</pub-id><pub-id pub-id-type="pmcid">PMC8045416</pub-id></element-citation></ref><ref id="B8-tropicalmed-10-00272"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kundrod</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Schmeler</surname><given-names>K.</given-names></name><name name-style="western"><surname>Richards-Kortum</surname><given-names>R.</given-names></name></person-group><article-title>Advances in technologies for cervical cancer detection in low-resource settings</article-title><source>Expert Rev. Mol. Diagn.</source><year>2019</year><volume>19</volume><fpage>695</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1080/14737159.2019.1648213</pub-id><pub-id pub-id-type="pmid">31368827</pub-id><pub-id pub-id-type="pmcid">PMC6862780</pub-id></element-citation></ref><ref id="B9-tropicalmed-10-00272"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartosik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moranova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Izadi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Strmiskova</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sebuyoya</surname><given-names>R.</given-names></name><name name-style="western"><surname>Holcakova</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hrstka</surname><given-names>R.</given-names></name></person-group><article-title>Advanced technologies towards improved HPV diagnostics</article-title><source>J. Med. Virol.</source><year>2024</year><volume>96</volume><fpage>e29409</fpage><pub-id pub-id-type="doi">10.1002/jmv.29409</pub-id><pub-id pub-id-type="pmid">38293790</pub-id></element-citation></ref><ref id="B10-tropicalmed-10-00272"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Contreras</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Carrasco-Gonz&#225;lez</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Linhares</surname><given-names>D.C.L.</given-names></name><name name-style="western"><surname>Corzo</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Campos-Villalobos</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Henao-D&#237;az</surname><given-names>A.</given-names></name><name name-style="western"><surname>Melchor-Mart&#237;nez</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>H.M.N.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Gonz&#225;lez</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Parra-Sald&#237;var</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Emergent Molecular Techniques Applied to the Detection of Porcine Viruses</article-title><source>Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>609</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci10100609</pub-id><pub-id pub-id-type="pmid">37888561</pub-id><pub-id pub-id-type="pmcid">PMC10610968</pub-id></element-citation></ref><ref id="B11-tropicalmed-10-00272"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name></person-group><source>Point-of-Care Testing. Clinical Laboratory Management</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2023</year><fpage>109</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/978-3-031-46420-1</pub-id></element-citation></ref><ref id="B12-tropicalmed-10-00272"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mota</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Guimar&#227;es</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Gandarilla</surname><given-names>A.M.D.</given-names></name><name name-style="western"><surname>Filho</surname><given-names>J.C.B.S.</given-names></name><name name-style="western"><surname>Brito</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Mari&#250;ba</surname><given-names>L.A.M.</given-names></name></person-group><article-title>Recombinase polymerase amplification in the molecular diagnosis of microbiological targets and its applications</article-title><source>Can. J. Microbiol.</source><year>2022</year><volume>68</volume><fpage>383</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1139/cjm-2021-0329</pub-id><pub-id pub-id-type="pmid">35394399</pub-id></element-citation></ref><ref id="B13-tropicalmed-10-00272"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otoo</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Schlappi</surname><given-names>T.S.</given-names></name></person-group><article-title>REASSURED Multiplex Diagnostics: A Critical Review and Forecast</article-title><source>Biosensors</source><year>2022</year><volume>12</volume><elocation-id>124</elocation-id><pub-id pub-id-type="doi">10.3390/bios12020124</pub-id><pub-id pub-id-type="pmid">35200384</pub-id><pub-id pub-id-type="pmcid">PMC8869588</pub-id></element-citation></ref><ref id="B14-tropicalmed-10-00272"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>H.</given-names></name></person-group><article-title>Helicase-dependent isothermal DNA amplification</article-title><source>EMBO Rep.</source><year>2004</year><volume>5</volume><fpage>795</fpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400200</pub-id><pub-id pub-id-type="pmid">15247927</pub-id><pub-id pub-id-type="pmcid">PMC1249482</pub-id></element-citation></ref><ref id="B15-tropicalmed-10-00272"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbieri</surname><given-names>D.</given-names></name><name name-style="western"><surname>Venturoli</surname><given-names>S.</given-names></name><name name-style="western"><surname>R&#246;sl</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rincon-Orozco</surname><given-names>B.</given-names></name></person-group><article-title>Detection of high-risk human papillomavirus type 16 and 18 using isothermal helicase-dependent amplification</article-title><source>Diagn. Microbiol. Infect. Dis.</source><year>2014</year><volume>79</volume><fpage>178</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2014.02.012</pub-id><pub-id pub-id-type="pmid">24666707</pub-id></element-citation></ref><ref id="B16-tropicalmed-10-00272"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Notomi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Okayama</surname><given-names>H.</given-names></name><name name-style="western"><surname>Masubuchi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yonekawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Amino</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hase</surname><given-names>T.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification of DNA</article-title><source>Nucleic Acids Res.</source><year>2000</year><volume>28</volume><fpage>e63</fpage><pub-id pub-id-type="doi">10.1093/nar/28.12.e63</pub-id><pub-id pub-id-type="pmid">10871386</pub-id><pub-id pub-id-type="pmcid">PMC102748</pub-id></element-citation></ref><ref id="B17-tropicalmed-10-00272"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Veigas</surname><given-names>B.</given-names></name><name name-style="western"><surname>Baptista</surname><given-names>P.V.</given-names></name></person-group><article-title>Isothermal Amplification of Nucleic Acids: The Race for the Next &#8220;Gold Standard&#8221;</article-title><source>Front. Sens.</source><year>2021</year><volume>2</volume><fpage>752600</fpage><pub-id pub-id-type="doi">10.3389/fsens.2021.752600</pub-id></element-citation></ref><ref id="B18-tropicalmed-10-00272"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kshirsagar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Politza</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Guan</surname><given-names>W.</given-names></name></person-group><article-title>High Fidelity Machine Learning-Assisted False Positive Discrimination in Loop-Mediated Isothermal Amplification Using Nanopore-Based Sizing and Counting</article-title><source>ACS Nano</source><year>2024</year><volume>18</volume><fpage>7170</fpage><pub-id pub-id-type="doi">10.1021/acsnano.3c12053</pub-id><pub-id pub-id-type="pmid">38393338</pub-id><pub-id pub-id-type="pmcid">PMC11197460</pub-id></element-citation></ref><ref id="B19-tropicalmed-10-00272"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Falco</surname><given-names>M.</given-names></name><name name-style="western"><surname>Colella</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abdelkarim</surname><given-names>J.A.Y.</given-names></name><name name-style="western"><surname>Antonacci</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scognamiglio</surname><given-names>V.</given-names></name><name name-style="western"><surname>De Felice</surname><given-names>M.</given-names></name></person-group><article-title>Helicase-dependent isothermal amplification turns biosensing into modern diagnostic technologies</article-title><source>Microchem. J.</source><year>2025</year><volume>216</volume><fpage>114772</fpage><pub-id pub-id-type="doi">10.1016/j.microc.2025.114772</pub-id></element-citation></ref><ref id="B20-tropicalmed-10-00272"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Contreras</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Gonz&#225;lez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Trujillo-Rodr&#237;guez</surname><given-names>G.d.J.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-S&#225;nchez</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Ancer-Rodr&#237;guez</surname><given-names>J.</given-names></name><name name-style="western"><surname>P&#233;rez-Maya</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Alvarez-Cuevas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Martinez-Fierro</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Marino-Mart&#237;nez</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Garza-Veloz</surname><given-names>I.</given-names></name></person-group><article-title>Isothermal Technologies for HPV Detection: Current Trends and Future Perspectives</article-title><source>Pathogens</source><year>2024</year><volume>13</volume><elocation-id>653</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens13080653</pub-id><pub-id pub-id-type="pmid">39204253</pub-id><pub-id pub-id-type="pmcid">PMC11357395</pub-id></element-citation></ref><ref id="B21-tropicalmed-10-00272"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weigl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Domingo</surname><given-names>G.</given-names></name><name name-style="western"><surname>LaBarre</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gerlach</surname><given-names>J.</given-names></name></person-group><article-title>Towards non- and minimally instrumented, microfluidics-based diagnostic devices</article-title><source>Lab Chip</source><year>2008</year><volume>8</volume><fpage>1999</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1039/b811314a</pub-id><pub-id pub-id-type="pmid">19023463</pub-id><pub-id pub-id-type="pmcid">PMC2776042</pub-id></element-citation></ref><ref id="B22-tropicalmed-10-00272"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lyu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ismagilov</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Han</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>F.</given-names></name></person-group><article-title>Self-partitioning SlipChip for slip-induced droplet formation and human papillomavirus viral load quantification with digital LAMP</article-title><source>Biosens. Bioelectron.</source><year>2020</year><volume>155</volume><elocation-id>112107</elocation-id><pub-id pub-id-type="doi">10.1016/j.bios.2020.112107</pub-id><pub-id pub-id-type="pmid">32090872</pub-id></element-citation></ref><ref id="B23-tropicalmed-10-00272"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mi</surname><given-names>S.</given-names></name></person-group><article-title>An integrated microfluidic detection system for the automated and rapid diagnosis of high-risk human papillomavirus</article-title><source>Analyst</source><year>2021</year><volume>146</volume><fpage>5102</fpage><lpage>5114</lpage><pub-id pub-id-type="doi">10.1039/D1AN00623A</pub-id><pub-id pub-id-type="pmid">34264258</pub-id></element-citation></ref><ref id="B24-tropicalmed-10-00272"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pandian</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kadimisetty</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>K.</given-names></name><name name-style="western"><surname>You</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name></person-group><article-title>Synergistically enhanced colorimetric molecular detection using smart cup: A case for instrument-free HPV-associated cancer screening</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><fpage>2637</fpage><lpage>2645</lpage><pub-id pub-id-type="doi">10.7150/thno.32224</pub-id><pub-id pub-id-type="pmid">31131058</pub-id><pub-id pub-id-type="pmcid">PMC6525999</pub-id></element-citation></ref><ref id="B25-tropicalmed-10-00272"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A portable all-in-one microfluidic device with real-time colorimetric LAMP for HPV16 and HPV18 DNA point-of-care testing</article-title><source>Biosens. Bioelectron.</source><year>2024</year><volume>248</volume><elocation-id>115968</elocation-id><pub-id pub-id-type="doi">10.1016/j.bios.2023.115968</pub-id><pub-id pub-id-type="pmid">38150799</pub-id></element-citation></ref><ref id="B26-tropicalmed-10-00272"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>J.</given-names></name></person-group><article-title>Lambda exonuclease assisted helicase-dependent amplification CRISPR/Cas12a detection of Listeria monocytogenes</article-title><source>Biochimie</source><year>2025</year><volume>235</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2025.06.002</pub-id><pub-id pub-id-type="pmid">40499611</pub-id></element-citation></ref><ref id="B27-tropicalmed-10-00272"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>He</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>K.</given-names></name><etal/></person-group><article-title>DMSO enhanced one-pot HDA-CRISPR/Cas12a biosensor for ultrasensitive detection of Monkeypox virus</article-title><source>Talanta</source><year>2025</year><volume>287</volume><fpage>127660</fpage><pub-id pub-id-type="doi">10.1016/j.talanta.2025.127660</pub-id><pub-id pub-id-type="pmid">39892116</pub-id></element-citation></ref><ref id="B28-tropicalmed-10-00272"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenison</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jaeckel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Klonoski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Latorra</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wiens</surname><given-names>J.</given-names></name></person-group><article-title>Rapid amplification/detection of nucleic acid targets utilizing a HDA/thin film biosensor</article-title><source>Analyst</source><year>2014</year><volume>139</volume><fpage>3763</fpage><lpage>3769</lpage><pub-id pub-id-type="doi">10.1039/C4AN00418C</pub-id><pub-id pub-id-type="pmid">24899216</pub-id></element-citation></ref><ref id="B29-tropicalmed-10-00272"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahalanabis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Do</surname><given-names>J.</given-names></name><name name-style="western"><surname>Almuayad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Klapperich</surname><given-names>C.M.</given-names></name></person-group><article-title>An integrated disposable device for DNA extraction and helicase dependent amplification</article-title><source>Biomed. Microdevices</source><year>2010</year><volume>12</volume><fpage>353</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1007/s10544-009-9391-8</pub-id><pub-id pub-id-type="pmid">20066496</pub-id><pub-id pub-id-type="pmcid">PMC2998058</pub-id></element-citation></ref><ref id="B30-tropicalmed-10-00272"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Song</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R.</given-names></name></person-group><article-title>Advances in isothermal nucleic acid amplification methods for hepatitis B virus detection</article-title><source>Analyst</source><year>2023</year><volume>148</volume><fpage>3708</fpage><lpage>3718</lpage><pub-id pub-id-type="doi">10.1039/D3AN00700F</pub-id><pub-id pub-id-type="pmid">37489761</pub-id></element-citation></ref><ref id="B31-tropicalmed-10-00272"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramalingam</surname><given-names>N.</given-names></name><name name-style="western"><surname>San</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Kai</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Mak</surname><given-names>M.Y.M.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>H.Q.</given-names></name></person-group><article-title>Microfluidic devices harboring unsealed reactors for real-time isothermal helicase-dependent amplification</article-title><source>Microfluid. Nanofluidics</source><year>2009</year><volume>7</volume><fpage>325</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1007/s10404-008-0378-1</pub-id><pub-id pub-id-type="pmid">32214955</pub-id><pub-id pub-id-type="pmcid">PMC7087983</pub-id></element-citation></ref><ref id="B32-tropicalmed-10-00272"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attia</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>W.T.</given-names></name><name name-style="western"><surname>Tandon</surname><given-names>R.</given-names></name></person-group><article-title>Heterogeneity Aware Two-Stage Group Testing</article-title><source>IEEE Trans. Signal Process.</source><year>2021</year><volume>69</volume><fpage>3977</fpage><pub-id pub-id-type="doi">10.1109/TSP.2021.3093785</pub-id><pub-id pub-id-type="pmid">37982073</pub-id><pub-id pub-id-type="pmcid">PMC8544931</pub-id></element-citation></ref><ref id="B33-tropicalmed-10-00272"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#246;derlund-Strand</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dillner</surname><given-names>J.</given-names></name></person-group><article-title>Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus</article-title><source>J. Clin. Microbiol.</source><year>2009</year><volume>47</volume><elocation-id>541</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.02007-08</pub-id><pub-id pub-id-type="pmid">19144817</pub-id><pub-id pub-id-type="pmcid">PMC2650955</pub-id></element-citation></ref><ref id="B34-tropicalmed-10-00272"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barreda-Garc&#237;a</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miranda-Castro</surname><given-names>R.</given-names></name><name name-style="western"><surname>de-los-Santos-&#193;lvarez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Miranda-Ordieres</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Lobo-Casta&#241;&#243;n</surname><given-names>M.J.</given-names></name></person-group><article-title>Helicase-dependent isothermal amplification: A novel tool in the development of molecular-based analytical systems for rapid pathogen detection</article-title><source>Anal. Bioanal. Chem.</source><year>2017</year><volume>410</volume><elocation-id>679</elocation-id><pub-id pub-id-type="doi">10.1007/s00216-017-0620-3</pub-id><pub-id pub-id-type="pmid">28932883</pub-id><pub-id pub-id-type="pmcid">PMC7079856</pub-id></element-citation></ref><ref id="B35-tropicalmed-10-00272"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamsisi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Benlghazi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kouach</surname><given-names>J.</given-names></name><name name-style="western"><surname>Laraqui</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ennaji</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Chauleur</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bourlet</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name></person-group><article-title>Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening</article-title><source>Viruses</source><year>2024</year><volume>16</volume><elocation-id>1852</elocation-id><pub-id pub-id-type="doi">10.3390/v16121852</pub-id><pub-id pub-id-type="pmid">39772162</pub-id><pub-id pub-id-type="pmcid">PMC11680343</pub-id></element-citation></ref><ref id="B36-tropicalmed-10-00272"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumvongpin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jearanaikool</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wilailuckana</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sae-ung</surname><given-names>N.</given-names></name><name name-style="western"><surname>Prasongdee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Daduang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wongsena</surname><given-names>M.</given-names></name><name name-style="western"><surname>Boonsiri</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kiatpathomchai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Swangvaree</surname><given-names>S.S.</given-names></name><etal/></person-group><article-title>High sensitivity, loop-mediated isothermal amplification combined with colorimetric gold-nanoparticle probes for visual detection of high risk human papillomavirus genotypes 16 and 18</article-title><source>J. Virol. Methods</source><year>2016</year><volume>234</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2016.04.008</pub-id><pub-id pub-id-type="pmid">27086727</pub-id></element-citation></ref><ref id="B37-tropicalmed-10-00272"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulinaizhaer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>G.</given-names></name></person-group><article-title>Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test</article-title><source>Virol. J.</source><year>2023</year><volume>20</volume><fpage>274</fpage><pub-id pub-id-type="doi">10.1186/s12985-023-02223-8</pub-id><pub-id pub-id-type="pmid">37996921</pub-id><pub-id pub-id-type="pmcid">PMC10668421</pub-id></element-citation></ref><ref id="B38-tropicalmed-10-00272"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamket</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sathianpitayakul</surname><given-names>P.</given-names></name><name name-style="western"><surname>Santanirand</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ratthawongjirakul</surname><given-names>P.</given-names></name></person-group><article-title>Implementation of helicase-dependent amplification with SYBR Green I for prompt naked-eye detection of bacterial contaminants in platelet products</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>3238</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-30410-8</pub-id><pub-id pub-id-type="pmid">36828935</pub-id><pub-id pub-id-type="pmcid">PMC9958189</pub-id></element-citation></ref><ref id="B39-tropicalmed-10-00272"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name></person-group><article-title>A simple and efficient method for potential point-of-care diagnosis of human papillomavirus genotypes: Combination of isothermal recombinase polymerase amplification with lateral flow dipstick and reverse dot blot</article-title><source>Anal. Bioanal. Chem.</source><year>2019</year><volume>411</volume><fpage>7451</fpage><lpage>7460</lpage><pub-id pub-id-type="doi">10.1007/s00216-019-02113-5</pub-id><pub-id pub-id-type="pmid">31588523</pub-id></element-citation></ref><ref id="B40-tropicalmed-10-00272"><label>40.</label><element-citation publication-type="webpage"><article-title>6 Ways to Minimize Contamination During PCR|labclinics.com</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.labclinics.com/2019/07/22/six-ways-to-minimize-contamination-during-pcr/?lang=en" ext-link-type="uri">https://www.labclinics.com/2019/07/22/six-ways-to-minimize-contamination-during-pcr/?lang=en</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-05-29">(accessed on 29 May 2025)</date-in-citation></element-citation></ref><ref id="B41-tropicalmed-10-00272"><label>41.</label><element-citation publication-type="webpage"><article-title>HPV Tests For Cervical Cancer Screening&#8212;PAHO/WHO|Pan American Health Organization</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.paho.org/en/topics/cervical-cancer/hpv-tests-cervical-cancer-screening" ext-link-type="uri">https://www.paho.org/en/topics/cervical-cancer/hpv-tests-cervical-cancer-screening</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-22">(accessed on 22 July 2025)</date-in-citation></element-citation></ref><ref id="B42-tropicalmed-10-00272"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Gonz&#225;lez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Garcia-Ramirez</surname><given-names>R.</given-names></name><name name-style="western"><surname>D&#237;az-Armas</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Esparza</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aguilar-Avelar</surname><given-names>C.</given-names></name><name name-style="western"><surname>Flores-Contreras</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-S&#225;nchez</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Delgado-Balderas</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Soto-Garc&#237;a</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ar&#225;iz-Hern&#225;ndez</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Automated elisa on-chip for the detection of anti-SARS-CoV-2 antibodies</article-title><source>Sensors</source><year>2021</year><volume>21</volume><elocation-id>6785</elocation-id><pub-id pub-id-type="doi">10.3390/s21206785</pub-id><pub-id pub-id-type="pmid">34695998</pub-id><pub-id pub-id-type="pmcid">PMC8539637</pub-id></element-citation></ref><ref id="B43-tropicalmed-10-00272"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Gonz&#225;lez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lara-Mayorga</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-S&#225;nchez</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Chapa</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>G.T.D.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>M.M.</given-names></name></person-group><article-title>Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: The change in color in LAMP-based assays quantitatively correlates with viral copy number</article-title><source>Anal. Methods</source><year>2021</year><volume>13</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1039/D0AY01658F</pub-id><pub-id pub-id-type="pmid">33399137</pub-id></element-citation></ref><ref id="B44-tropicalmed-10-00272"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kundrod</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Barra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Natoli</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Coole</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Santhanaraj</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lorenzoni</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mavume</surname><given-names>C.</given-names></name><etal/></person-group><article-title>An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings</article-title><source>Sci. Transl. Med.</source><year>2023</year><volume>15</volume><fpage>eabn4768</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abn4768</pub-id><pub-id pub-id-type="pmid">37343083</pub-id><pub-id pub-id-type="pmcid">PMC10566637</pub-id></element-citation></ref><ref id="B45-tropicalmed-10-00272"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zamani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Robson</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bono</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Furst</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Klapperich</surname><given-names>C.M.</given-names></name></person-group><article-title>Electrochemical Strategy for Low-Cost Viral Detection</article-title><source>ACS Cent. Sci.</source><year>2021</year><volume>7</volume><fpage>963</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.1c00186</pub-id><pub-id pub-id-type="pmid">34235257</pub-id><pub-id pub-id-type="pmcid">PMC8227598</pub-id></element-citation></ref><ref id="B46-tropicalmed-10-00272"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsiang</surname><given-names>E.</given-names></name><name name-style="western"><surname>Little</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Haguma</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hanrahan</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Katamba</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cattamanchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Vassall</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dowdy</surname><given-names>D.</given-names></name></person-group><article-title>Higher cost of implementing Xpert<sup>&#174;</sup> MTB/RIF in Ugandan peripheral settings: Implications for cost-effectiveness</article-title><source>Int. J. Tuberc. Lung Dis.</source><year>2016</year><volume>20</volume><fpage>1212</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.5588/ijtld.16.0200</pub-id><pub-id pub-id-type="pmid">27510248</pub-id><pub-id pub-id-type="pmcid">PMC5018405</pub-id></element-citation></ref><ref id="B47-tropicalmed-10-00272"><label>47.</label><element-citation publication-type="book"><source>Putting HIV and HCV to the Test</source><edition>2nd ed.</edition><publisher-name>M&#233;decins Sans Fronti&#232;res Access Campaign</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2015</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://msfaccess.org/putting-hiv-and-hcv-test-2nd-ed-2015" ext-link-type="uri">https://msfaccess.org/putting-hiv-and-hcv-test-2nd-ed-2015</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-22">(accessed on 22 July 2025)</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig position="float" id="tropicalmed-10-00272-f001" orientation="portrait"><label>Figure 1</label><caption><p>POC Platform components. (<bold>A</bold>) Microfluidic device. (<bold>B</bold>) Portable Warming Mat with its respective measurements. (<bold>C</bold>) Portable electrophoresis chamber. (<bold>D</bold>) Comprehensive schematic representation of the POC platform.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="tropicalmed-10-00272-g001.jpg"/></fig><fig position="float" id="tropicalmed-10-00272-f002" orientation="portrait"><label>Figure 2</label><caption><p>Standardization of HDA conditions. (<bold>A</bold>,<bold>B</bold>). Evaluation of incubation temperatures ranging from 55 &#176;C to 65 &#176;C to determine the optimal conditions for HDA of HPV genotypes 16 (<bold>A</bold>) and 18 (<bold>B</bold>). (<bold>C</bold>) Assessment of incubation times using HPV 18-specific primers to identify the minimum time required for detectable amplification. (<bold>D</bold>) Determination of the LOD of the HDA assay, using a copy number (cp) range of 30 to 1, for HPV genotypes 16 and 18.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="tropicalmed-10-00272-g002.jpg"/></fig><fig position="float" id="tropicalmed-10-00272-f003" orientation="portrait"><label>Figure 3</label><caption><p>Working POC Platform for HPV detection. (<bold>A</bold>) A set of microfluidic devices was incubated at 65 &#176;C utilizing a portable warming mat for temperature control. (<bold>B</bold>,<bold>C</bold>) Gel electrophoresis results showing positive bands for genotypes 16 (<bold>B</bold>) and 18 (<bold>C</bold>). (<bold>D</bold>) Fluorescence visualization of samples stained with SYBR Safe was performed on the microfluidic device using the electrophoresis chamber.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="tropicalmed-10-00272-g003.jpg"/></fig><fig position="float" id="tropicalmed-10-00272-f004" orientation="portrait"><label>Figure 4</label><caption><p>Schematic of a fully functional mobile molecular laboratory designed for use in remote areas, highlighting its main components and their estimated costs, with a total cost of less than $2500 USD.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="tropicalmed-10-00272-g004.jpg"/></fig><table-wrap position="float" id="tropicalmed-10-00272-t001" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00272-t001_Table 1</object-id><label>Table 1</label><caption><p>Real-time PCR genotyping results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Samples</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Results/Genotype</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">45</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</td></tr></tbody></table><table-wrap-foot><fn><p>(+): Genotype detected; (&#8722;): Genotype not detected.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tropicalmed-10-00272-t002" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00272-t002_Table 2</object-id><label>Table 2</label><caption><p>Sequence of primers used for the HDA assay.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Size Amplicon</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Forward HPV-16</td><td align="center" valign="middle" rowspan="1" colspan="1">AAGCAGAACCGGACAGAGCCCA</td><td rowspan="2" align="center" valign="middle" colspan="1">83 bp</td><td rowspan="2" align="center" valign="middle" colspan="1">[<xref rid="B15-tropicalmed-10-00272" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Reverse HPV-16</td><td align="center" valign="middle" rowspan="1" colspan="1">GCTTTGTACGCACAACCGAAGCG</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Forward HPV-18</td><td align="center" valign="middle" rowspan="1" colspan="1">ACCAGCCCGACGAGCCGAACC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">108 bp</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B15-tropicalmed-10-00272" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse HPV-18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTCGAAGGTCGTCTGCTGAGCTTT</td></tr></tbody></table><table-wrap-foot><fn><p>bp: base pairs.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tropicalmed-10-00272-t003" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00272-t003_Table 3</object-id><label>Table 3</label><caption><p>Cost of the components of the POC platform.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Component</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cost (USD)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Microfluidic device (PMMA)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Portable warming mat</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Electrophoresis chamber</td><td align="center" valign="middle" rowspan="1" colspan="1">300</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>320.10</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>The total cost of the components required to perform the HDA assay integrated into the microfluidic platform is highlighted in bold.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tropicalmed-10-00272-t004" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00272-t004_Table 4</object-id><label>Table 4</label><caption><p>Determination of the sensitivity and specificity of the HDA assay.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">HDA Assay</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Real-Time PCR</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Total</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Sensitivity</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Specificity</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Kappa (95% CI, <italic toggle="yes">p</italic>-Value)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">+</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td rowspan="2" align="center" valign="middle" colspan="1">95.52%</td><td rowspan="2" align="center" valign="middle" colspan="1">100%</td><td rowspan="2" align="center" valign="middle" colspan="1">0.936 (84.24&#8211;99.92, <italic toggle="yes">p</italic> &lt; 0.05)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>CI: Confidence interval.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>